Rasonque: FDA Approves Pancreatic Cancer Pill

Zeit Online

Lean Left

Factuality

Ownership

In the USA, a new remedy for pancreatic cancer has been approved: Daraxonrasib. How it works, when it comes – and what this means for other types of tumours

Cumhuriyet

Lean Left

Factuality

Ownership

The FDA has officially approved Rasonque (daraxonrasib), a groundbreaking drug for treating pancreatic cancer, one of the deadliest types of cancer. Clinical trials have documented that the drug doubles the survival rate of patients with advanced-stage cancer.

Sapo

Lean Right

Factuality

Ownership

The Food and Drug Administration (FDA) has given green light to daraxonrasib, a drug that promises to almost double the survival of patients with advanced pancreatic cancer. In Europe, the equivalent agency has already accelerated the...